
J.H. Whitney & Co
Description
J.H. Whitney & Co. holds a significant place in the history of private equity, often credited as one of the earliest venture capital firms in the United States. Founded in 1946 by John Hay Whitney, the firm pioneered the concept of providing capital to emerging businesses, laying foundational groundwork for the modern private equity industry. Over its active decades, J.H. Whitney focused on small and middle-market buyouts and recapitalizations, targeting growth-oriented companies across a diverse range of sectors.
Historically, the firm's investment strategy encompassed various industries, including consumer products, healthcare, specialty manufacturing, and business services. J.H. Whitney raised multiple funds throughout its operational history, with its final fund, J.H. Whitney VII, L.P., closing in 2005 with a substantial $750 million in committed capital. During its active investment period, the firm typically deployed equity investments ranging from $25 million to $100 million for control-oriented transactions, aiming to partner with management teams to drive growth and operational improvements.
However, J.H. Whitney & Co. ceased new investment activities around 2016 and is now considered an inactive firm. While its legacy as an industry pioneer remains, the firm is no longer making new investments or providing capital to startups and growth companies. Consequently, there are no current "typical first cheque" sizes to report, as their investment operations have concluded.
Investor Profile
J.H. Whitney & Co has backed more than 39 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 23% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States, Japan.
- Strong thematic focus on Software, Health Care, Medical.
Stage Focus
- Series Unknown (33%)
- Private Equity (18%)
- Series C (13%)
- Series B (13%)
- Series D (8%)
- Series A (8%)
- Series E (3%)
- Series F (3%)
- Series G (3%)
Country Focus
- United States (97%)
- Japan (3%)
Industry Focus
- Software
- Health Care
- Medical
- Internet
- Electronics
- Mhealth
- Telecommunications
- E-commerce
- Finance
- B2b
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.